Connection

Wenjie Tan to Drug Repositioning

Back to Details
This is a "connection" page, showing publications Wenjie Tan has written about Drug Repositioning.
Wenjie Tan
Connection Strength
0.015
Drug Repositioning
  1. Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease. Signal Transduct Target Ther. 2021 05 29; 6(1):212.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.